Literature DB >> 20881889

The Menopause-Specific Quality of Life Questionnaire: psychometric evaluation among breast cancer survivors.

Jill V Radtke1, Lauren Terhorst, Susan M Cohen.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the psychometric properties of the Menopause-Specific Quality of Life Questionnaire (MENQOL) in a sample of breast cancer survivors experiencing menopausal symptoms.
METHODS: This was a secondary analysis of MENQOL psychometric data from two larger parent studies investigating acupuncture for the relief of menopausal symptoms among breast cancer survivors. Reliability was assessed for each subscale of the MENQOL via (1) internal consistency reliability with Cronbach α and (2) test-retest reliability at multiple follow-up points with intraclass correlation coefficients and r. Convergent and discriminant validities were assessed via correlations of the vasomotor and psychosocial MENQOL subscales with select items in the Kupperman index and daily symptom diary. A principal components analysis was performed to determine construct validity.
RESULTS: For each subscale, Cronbach α was 0.70 or greater. All subscale test-retest reliabilities at first follow-up were significant and at least moderately correlated (≥ 0.450; r's and intraclass correlation coefficients). Convergent validity was moderate between the vasomotor and psychosocial subscales and the symptom diary (r ≥ 0.410, P < 0.001) and larger between these domains and the Kupperman index (r ≥ 0.614, P < 0.001). In the same subscales, discriminant validity was supported by low, nonsignificant correlations (r ≤ 0.176, P > 0.05). The principal components analysis revealed a latent structure nearly identical to the prespecified instrument domains, with the exception of the physical domain.
CONCLUSIONS: With results comparable with those obtained in previous psychometric work, the MENQOL seems to be a reliable and valid instrument to assess quality of life in postmenopausal breast cancer survivors.

Entities:  

Mesh:

Year:  2011        PMID: 20881889      PMCID: PMC3017657          DOI: 10.1097/gme.0b013e3181ef975a

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  22 in total

Review 1.  Examining test-retest reliability: an intra-class correlation approach.

Authors:  Miaofen Yen; Li-Hua Lo
Journal:  Nurs Res       Date:  2002 Jan-Feb       Impact factor: 2.381

2.  The menopausal symptom experience in young mid-life women with breast cancer.

Authors:  M T Knobf
Journal:  Cancer Nurs       Date:  2001-06       Impact factor: 2.592

3.  The risk of premature menopause induced by chemotherapy for early breast cancer.

Authors:  E E Lower; R Blau; P Gazder; R Tummala
Journal:  J Womens Health Gend Based Med       Date:  1999-09

4.  Factor analysis, causal indicators and quality of life.

Authors:  P M Fayers; D J Hand
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

5.  The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.

Authors:  Donna L Lamping; Sara Schroter; Patrick Marquis; Alexia Marrel; Isabelle Duprat-Lomon; Pierre-Philippe Sagnier
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

6.  A menopause-specific quality of life questionnaire: development and psychometric properties.

Authors:  J R Hilditch; J Lewis; A Peter; B van Maris; A Ross; E Franssen; G H Guyatt; P G Norton; E Dunn
Journal:  Maturitas       Date:  1996-07       Impact factor: 4.342

7.  Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study.

Authors:  Morrie M Gelfand; Michèle Moreau; Normand J Ayotte; John R Hilditch; Betty A Wong; Catherine Y Lau
Journal:  Menopause       Date:  2003 Jan-Feb       Impact factor: 2.953

8.  The prevalence of menopausal symptoms in patients treated for breast cancer.

Authors:  P A Canney; M Q Hatton
Journal:  Clin Oncol (R Coll Radiol)       Date:  1994       Impact factor: 4.126

9.  Association of waking episodes with menopausal hot flushes.

Authors:  Y Erlik; I V Tataryn; D R Meldrum; P Lomax; J G Bajorek; H L Judd
Journal:  JAMA       Date:  1981-05-01       Impact factor: 56.272

10.  Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

Authors:  Nadine Tchen; Helen G Juffs; Fiona P Downie; Qi-Long Yi; Hanxian Hu; Irene Chemerynsky; Mark Clemons; Michael Crump; Paul E Goss; David Warr; Mary E Tweedale; Ian F Tannock
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

View more
  14 in total

1.  Psychometric properties of the Menopause Specific Quality of Life questionnaire among Thai women with a history of breast cancer.

Authors:  Warunee Phligbua; Ellen M Lovie Smith; Debra L Barton
Journal:  Eur J Oncol Nurs       Date:  2018-08-25       Impact factor: 2.398

2.  Differences in symptom clusters before and twelve months after breast cancer surgery.

Authors:  Melissa Mazor; Janine K Cataldo; Kathryn Lee; Anand Dhruva; Bruce Cooper; Steven M Paul; Kimberly Topp; Betty J Smoot; Laura B Dunn; Jon D Levine; Yvette P Conley; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2017-12-19       Impact factor: 2.398

3.  Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.

Authors:  Caroline S Dorfman; Sarah S Arthur; Gretchen G Kimmick; Kelly W Westbrook; Paul Kelly Marcom; Cheyenne Corbett; Sara N Edmond; Rebecca A Shelby
Journal:  Menopause       Date:  2019-08       Impact factor: 2.953

4.  Validation of the MENQOL for use with women who have been treated for gynecologic or breast cancer.

Authors:  Catherine Dolye; Lauran Adams; Alison McAndrew; Stephanie Burlein-Hall; Tracey DasGupta; Jennie Blake; Margaret Fitch
Journal:  Can Oncol Nurs J       Date:  2018-07-01

Review 5.  Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.

Authors:  Iris Bartula; Kerry A Sherman
Journal:  Breast Cancer Res Treat       Date:  2013-09-08       Impact factor: 4.872

6.  Psychometric properties of the Chinese version of the Menopause-Specific Quality-of-Life questionnaire.

Authors:  Guangning Nie; Hongyan Yang; Jian Liu; ChunMei Zhao; Xiaoyun Wang
Journal:  Menopause       Date:  2017-05       Impact factor: 2.953

Review 7.  Assessment of the climacteric syndrome: a narrative review.

Authors:  Marina Sourouni; Martina Zangger; Livia Honermann; Dolores Foth; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2021-07-06       Impact factor: 2.344

8.  What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.

Authors:  Martha Hickey; Alison Trainer; Sabine Braat; Mary-Ann Davey; Efrosinia Krejany; John Wark
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

9.  Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study.

Authors:  Salvatore Giovanni Vitale; Salvatore Caruso; Agnese Maria Chiara Rapisarda; Stefano Cianci; Antonio Cianci
Journal:  Prz Menopauzalny       Date:  2018-04-11

10.  Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial.

Authors:  Ioana R Marian; Megan Goff; Jennifer A E Williams; Malvika Gulati; Mae Chester-Jones; Anne Francis; Marion Watson; Tonia L Vincent; Sue Woollacott; Charles Mackworth-Young; Victoria Glover; Dominic Furniss; Matthew Gardiner; Sarah E Lamb; Katy Vincent; Vicki S Barber; Joanna Black; Susan J Dutton; Fiona E Watt
Journal:  Pilot Feasibility Stud       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.